Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Femasys Inc

FEMY
Current price
1.12 USD +0.01 USD (+0.90%)
Last closed 1.09 USD
ISIN US31447E1055
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 24 900 736 USD
Yield for 12 month +250.00 %
1Y
3Y
5Y
10Y
15Y
FEMY
21.11.2021 - 28.11.2021

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia. Address: 3950 Johns Creek Court, Suwanee, GA, United States, 30024

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.75 USD

P/E ratio

Dividend Yield

Current Year

+1 071 970 USD

Last Year

+1 206 218 USD

Current Quarter

+221 484 USD

Last Quarter

+271 140 USD

Current Year

-216 084 USD

Last Year

+764 280 USD

Current Quarter

-65 776 USD

Last Quarter

-41 284 USD

Key Figures FEMY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -16 119 600 USD
Operating Margin TTM -2023.69 %
PE Ratio
Return On Assets TTM -59.54 %
PEG Ratio
Return On Equity TTM -138.37 %
Wall Street Target Price 8.75 USD
Revenue TTM 950 096 USD
Book Value 0.51 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -30.9 %
Dividend Yield
Gross Profit TTM 764 280 USD
Earnings per share -0.84 USD
Diluted Eps TTM -0.84 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics FEMY

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History FEMY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation FEMY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 19.4065
Price Sales TTM 26.2087
Enterprise Value EBITDA 0.2361
Price Book MRQ 2.2134

Financials FEMY

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators FEMY

For 52 weeks

0.29 USD 4.75 USD
50 Day MA 1.09 USD
Shares Short Prior Month 543 305
200 Day MA 1.2 USD
Short Ratio 3.53
Shares Short 550 780
Short Percent 3.14 %